156 related articles for article (PubMed ID: 37641579)
1. Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial.
Shefner JM; Jacobsen B; Kupfer S; Malik FI; Meng L; Wei J; Wolff AA; Rudnicki SA
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):162-169. PubMed ID: 37641579
[TBL] [Abstract][Full Text] [Related]
2. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving
Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Butzner M; Chiò A; Andrews JA; Genge A; Hughes DA; Jackson CE; Lechtzin N; Miller TM; Shefner JM
J Med Econ; 2023; 26(1):488-493. PubMed ID: 36930042
[TBL] [Abstract][Full Text] [Related]
3. COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Shefner JM; Al-Chalabi A; Andrews JA; Chio A; De Carvalho M; Cockroft BM; Corcia P; Couratier P; Cudkowicz ME; Genge A; Hardiman O; Heiman-Patterson T; Henderson RD; Ingre C; Jackson CE; Johnston W; Lechtzin N; Ludolph A; Maragakis NJ; Miller TM; Mora Pardina JS; Petri S; Simmons Z; Van Den Berg LH; Zinman L; Kupfer S; Malik FI; Meng L; Simkins TJ; Wei J; Wolff AA; Rudnicki SA
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):523-534. PubMed ID: 37254449
[No Abstract] [Full Text] [Related]
4. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19.
Brooks BR; Pioro EP; Katz J; Takahashi F; Takei K; Zhang J; Apple S
Muscle Nerve; 2022 Feb; 65(2):180-186. PubMed ID: 34816454
[TBL] [Abstract][Full Text] [Related]
5. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of
Shefner JM; Andrews JA; Genge A; Jackson C; Lechtzin N; Miller TM; Cockroft BM; Meng L; Wei J; Wolff AA; Malik FI; Bodkin C; Brooks BR; Caress J; Dionne A; Fee D; Goutman SA; Goyal NA; Hardiman O; Hayat G; Heiman-Patterson T; Heitzman D; Henderson RD; Johnston W; Karam C; Kiernan MC; Kolb SJ; Korngut L; Ladha S; Matte G; Mora JS; Needham M; Oskarsson B; Pattee GL; Pioro EP; Pulley M; Quan D; Rezania K; Schellenberg KL; Schultz D; Shoesmith C; Simmons Z; Statland J; Sultan S; Swenson A; Berg LHVD; Vu T; Vucic S; Weiss M; Whyte-Rayson A; Wymer J; Zinman L; Rudnicki SA
Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):287-299. PubMed ID: 32969758
[TBL] [Abstract][Full Text] [Related]
6. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
8. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R.
Jackson C; De Carvalho M; Genge A; Heiman-Patterson T; Shefner JM; Wei J; Wolff AA
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):506-512. PubMed ID: 30379086
[TBL] [Abstract][Full Text] [Related]
9. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and motor impairment in ALS: Italian validation of ALSAQ.
Palmieri A; Sorarù G; Lombardi L; D'Ascenzo C; Baggio L; Ermani M; Pegoraro E; Angelini C
Neurol Res; 2010 Feb; 32(1):32-40. PubMed ID: 20092693
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
[TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis.
Prell T; Witte OW; Gunkel A; Grosskreutz J
Aging Ment Health; 2020 Dec; 24(12):1963-1967. PubMed ID: 31317778
[TBL] [Abstract][Full Text] [Related]
13. Electrical impedance myography correlates with standard measures of ALS severity.
Rutkove SB; Caress JB; Cartwright MS; Burns TM; Warder J; David WS; Goyal N; Maragakis NJ; Benatar M; Sharma KR; Narayanaswami P; Raynor EM; Watson ML; Shefner JM
Muscle Nerve; 2014 Mar; 49(3):441-3. PubMed ID: 24273034
[TBL] [Abstract][Full Text] [Related]
14. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
15. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
[TBL] [Abstract][Full Text] [Related]
16. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
[No Abstract] [Full Text] [Related]
17. Preliminary evaluation of the sensitivity to change of DE-STA motor unit number estimation in the upper trapezius muscle in amyotrophic lateral sclerosis.
Ives CT; Findlater K; Shoesmith CL; Doherty TJ
Clin Neurophysiol; 2015 Jul; 126(7):1427-34. PubMed ID: 25453610
[TBL] [Abstract][Full Text] [Related]
18. Clinical and electrophysiological examination of pinch strength in patients with amyotrophic lateral sclerosis.
Lee JD; Heshmat S; Heggie S; Thorpe KA; McCombe PA; Henderson RD
Muscle Nerve; 2021 Jan; 63(1):108-113. PubMed ID: 33118631
[TBL] [Abstract][Full Text] [Related]
19. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
[TBL] [Abstract][Full Text] [Related]
20. Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
Andrews JA; Meng L; Kulke SF; Rudnicki SA; Wolff AA; Bozik ME; Malik FI; Shefner JM
JAMA Neurol; 2018 Jan; 75(1):58-64. PubMed ID: 29181534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
